Key result
Adenosine analogs trigger coronary artery relaxation through complex signaling beyond direct adenylate cyclase stimulation.
Adenosine receptor-mediated coronary artery relaxation involves cAMP, but the inability of certain analogs to stimulate adenylate cyclase suggests complex signaling mechanisms beyond a single A2 receptor.
Answers are grounded in this paper and cite their sources.
Does not yet guide clinical coronary vasomotor therapy; leaves open complex cAMP-independent adenosine pathways for targeted investigation.
We investigated the involvement of adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) in adenosine (ADO) receptor-mediated coronary artery relaxation. Rings from left anterior descending coronary artery, with the endothelium mechanically removed, contracted with prostaglandin F2 alpha and relaxed in a concentration-dependent manner to ADO, 2-chloroadenosine (CAD), l-N6-(2-phenylisopropyl)adenosine (R-PIA), and 5'-(N-ethylcarboxamido)adenosine (NECA). These relaxations were blocked by addition of the ADO receptor antagonist 8-(sulfophenyl)theophylline (8-SPT), indicating ADO receptor involvement. In an endothelium-free membrane preparation, ADO, CAD, and R-PIA all stimulated adenylate cyclase activity in a concentration-dependent manner, and these responses were blocked by 8-SPT. The increase in adenylate cyclase activity produced by ADO, CAD, and R-PIA was completely dependent on the presence of guanosine 5'-triphosphate, suggesting G protein involvement. Surprisingly, NECA and CGS-21680 did not increase adenylate cyclase activity. Unlike atrial natriuretic factor, neither NECA, CAD, R-PIA, nor ADO increased guanylate cyclase activity, suggesting that cGMP is not involved in ADO receptor-mediated relaxation. Data presented in this study support the hypothesis that ADO receptor-mediated coronary artery relaxation may involve cAMP; however, the inability of NECA and CGS-21680 to stimulate adenylate cyclase suggests that the ADO receptor-signaling mechanisms in coronary artery may be more complicated than agonist interaction with a single adenylate cyclase-coupled A2 adenosine receptor.
No takes yet. Share an insight, caveat, or question.
Cushing et al. (1991) studied this question. Adenosine and analogs (ADO, CAD, R-PIA, NECA) was evaluated on Coronary artery relaxation and adenylate cyclase activity. Adenosine receptor-mediated coronary artery relaxation may involve cAMP, but the inability of NECA and CGS-21680 to stimulate adenylate cyclase suggests a more complex signaling mechanism.
Synapse has enriched 10 related papers. Consider them for comparative context: